WASHINGTON, D.C.: U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. announced a significant restructuring of federal health agencies this week, including cutting 10,000 jobs and centralizing certain functions of the FDA, CDC, and other agencies under his control.
The job cuts include:
With these cuts and 10,000 recent voluntary departures, the total number of full-time employees at HHS is expected to drop from 82,000 to 62,000.
Kennedy said the changes will make HHS more efficient and save taxpayer money, stating: “Our goal is to Make America Healthy Again.”
President Donald Trump and Elon Musk, who leads a government cost-cutting initiative, have been reducing federal staff as part of a broader plan to shrink government agencies. Trump recently ordered all agencies to prepare for more layoffs, and the White House is now reviewing those plans.
Experts warn that while reorganizing large agencies like HHS can be helpful, these cuts go further, potentially affecting government services. “This is not just restructuring—it’s a deep reduction in the federal workforce,” said Larry Levitt, a health policy expert.
The FDA assured that job cuts would not affect drug, food, or medical device inspectors; however, some experts warn that they could lead to delays in drug approvals.
Other Key Changes:
The restructuring will also centralize communications, human resources, IT, and policy planning across the FDA, CDC, and NIH. HHS said it will also create a new Office of Strategy to guide policy decisions.
At this time, no additional job cuts are planned.